Medine.co.uk

Ondansetron 8mg Tablets

Informations for option: Ondansetron 8mg Tablets, show other option
Document: leaflet MAH BRAND_PLPI 04423-0531 change

PACKAGE LEAFLET: INFORMATION FOR THE USER

ZOFRAN® 8MG TABLETS / ONDANSETRON 8MG TABLETS

_(ondansetron hydrochloride dihydrate)_

Your tablets are available using the above names, but will be referred to as Zofran Tablets throughout this leaflet. Zofran Tablets are available in the following strengths: 4mg & 8mg.

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

■    Keep this leaflet. You may need to read it again.

■    If you have any further questions about your illness or your medicine, ask your doctor, nurse or pharmacist.

■    This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.

■    If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet:

1.    What Zofran Tablets are and what they are used for

2.    What you need to know before you take Zofran Tablets

3.    How to take Zofran Tablets

4.    Possible side effects

5.    How to store Zofran Tablets

6.    Contents of the pack and other information

1.    What Zofran Tablets are and what they are used for

Zofran Tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Zofran Tablets are used for:

■    preventing nausea and vomiting caused by chemotherapy (in adults and children) or radiotherapy for cancer (adults only)

■    preventing nausea and vomiting after surgery (adults only).

Ask your doctor, nurse or pharmacist if you would like any further explanation about these uses.

2.    What you need to know before you take Zofran Tablets

Do not take Zofran Tablets if:

■    you are taking apomorphine (used to treat Parkinson's disease)

■    you are allergic (hypersensitive) to ondansetron or any of the other ingredients in Zofran Tablets (listed in section 6).

If you are not sure, talk to your doctor, nurse or pharmacist before taking Zofran Tablets.

Warnings and precautions

Check with your doctor, nurse or pharmacist before taking Zofran Tablets if:

■    you have ever had heart problems (e.g. congestive heart failure which causes shortness of breath and swollen ankles)

■    you have an uneven heart beat (arrhythmias)

■    you are allergic to medicines similar to ondansetron, such as granisetron or palonosetron

■    you have liver problems

■    you have a blockage in your gut

■    you have problems with the levels of salts in your blood, such as potassium, sodium and magnesium.

If you are not sure if any of the above apply to you, talk to your doctor, nurse or pharmacist before taking Zofran Tablets.

Other medicines and Zofran Tablets

Please tell your doctor, nurse or pharmacist if you are taking or have recently taken or might take other medicines. This includes medicines that you buy without a prescription and herbal medicines. This is because Zofran Tablets can affect the way some medicines work. Also some other medicines can affect the way Zofran Tablets work.

In particular, tell your doctor, nurse or pharmacist if you are taking any of the following medicines:

■    carbamazepine or phenytoin used to treat epilepsy

■    rifampicin used to treat infections such as tuberculosis (TB)

■    antibiotics such as erythromycin or ketoconazole

■    anti-arrhythmic medicines used to treat an uneven heart beat

■    beta-blocker medicines used to treat certain heart or eye problems, anxiety or prevent migraines

■    tramadol, a pain killer

■    medicines that affect the heart (such as haloperidol or methadone)

■    cancer medicines (especially anthracyclines and trastuzumab)

■    SSRIs (selective serotonin reuptake inhibitors) used to treat depression and/or anxiety including fluoxetine, paroxetine, sertraline, fluvoxamine, citalopram, escitalopram

■    SNRIs (serotonin noradrenaline reuptake inhibitors) used to treat depression and/or anxiety including venlafaxine, duloxetine.

If you are not sure if any of the above applies to you, talk to your doctor, nurse or pharmacist before having Zofran Tablets.

Pregnancy and breast-feeding

It is not known if Zofran Tablets are safe during pregnancy. If you are pregnant, think you are pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking Zofran tablets.

Do not breast-feed if you are taking Zofran Tablets. This is because small amounts pass into the mother's milk. Ask your doctor or midwife for advice.

Important information about some of the ingredients of Zofran Tablets

This medicine contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, speak to your doctor before taking this medicine.

3. How to take Zofran Tablets

Always take Zofran Tablets exactly as your doctor has told you. You should check with your doctor, nurse or pharmacist if you are not sure. The dose you have been prescribed will depend on the treatment you are having.

To prevent nausea and vomiting from chemotherapy or radiotherapy

On the day of chemotherapy or radiotherapy

■    the usual adult dose is 8mg taken one to two hours before treatment and another 8mg twelve hours after.

On the following days

■    the usual adult dose is 8mg twice a day

■    this may be given for up to 5 days.

Children aged over 6 months and adolescents

The doctor will decide the dose depending on the child's size

(body surface area) or weight. Look at the label for more

information.

■    the usual dose for a child is up to 4mg twice a day

■    this can be given for up to 5 days.

To prevent nausea and vomiting after an operation

The usual adult dose is 16mg before your operation

Children aged over 1 month and adolescents:

It is recommended that Zofran Tablets is given as an injection.

Patients with moderate or severe liver problems

The total daily dose should not be more than 8mg.

Zofran Tablets should start to work within one or two hours of taking a dose.

If you are sick (vomit) within one hour of taking a dose

■    take the same dose again

■    otherwise, do not take more Zofran Tablets than the label says.

If you continue to feel sick, tell your doctor or nurse.

If you take more Zofran Tablets than you should

If you or your child take more Zofran Tablets than you should, talk to a doctor or go to a hospital straight away.

Take the medicine pack with you.

If you forget to take Zofran Tablets

If you miss a dose and feel sick or vomit:

■    take Zofran Tablets as soon as possible, then

■    take your next tablet at the usual time (as shown on the label)

■    do not take a double dose to make up for a forgotten dose.

If you miss a dose but do not feel sick

■    take the next dose as shown on the label

■    do not take a double dose to make up for a forgotten dose.

4. Possible side effects

Like all medicines, Zofran Tablets can cause side effects, although not everybody gets them.

Allergic reactions

If you have an allergic reaction, stop taking it and see a doctor straight away. The signs may include:

■    sudden wheezing and chest pain or chest tightness

■    swelling of your eyelids, face, lips, mouth or tongue

■    skin rash - red spots or lumps under your skin (hives) anywhere on your body

■    collapse.

Other side effects include:

Very common (may affect more than 1 in 10 people)

■    headache.

Common (may affect up to 1 in 10 people)

■    a feeling of warmth or flushing

■    constipation

■    changes to liver function test results (if you take Zofran Tablets with a medicine called cisplatin, otherwise this side effect is uncommon).

Uncommon (may affect up to 1 in 100 people)

■    hiccups

■    low blood pressure, which can make you feel faint or dizzy

■    uneven heart beat

■    chest pain

■    fits

■    unusual body movements or shaking.

Rare (may affect up to 1 in 1,000 people)

■    feeling dizzy or light headed

■    blurred vision

■    disturbance in heart rhythm (sometimes causing a sudden loss of consciousness).

Very rare (may affect up to 1 in 10,000 people)

■    poor vision or temporary loss of eyesight, which usually comes back within 20 minutes.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.

By reporting side effects you can help provide more information on the safety of this medicine.

5.    How to store Zofran Tablets

■    Keep out of the sight and reach of children.

■    Do not store above 30°C.

■    If your tablets appear discoloured or show any other signs of deterioration, take them to your pharmacist who will advise you.

■    If your doctor stops your treatment, do not keep any leftover tablets unless your doctor tells you to. Return any unused tablets to your pharmacist.

■    Do not use the tablets after the expiry date on the tablet foil or carton. The expiry date refers to the last day of that month.

■    Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6.    Contents of the pack and other information

What Zofran Tablets contain

Active ingredient: ondansetron 8mg (as ondansetron hydrochloride dihydrate).

Other ingredients: lactose anhydrous, pregelatinised maize starch, microcrystalline cellulose, magnesium stearate, hypromellose, titanium dioxide (E171) and iron oxide (E172).

What Zofran Tablets look like and contents of the pack

Each Zofran Tablet is yellow, oval, film coated, and is engraved "Glaxo" on one face and "8" on the reverse.

Packs contain 15 x 8mg tablets.

Manufacturer

Your medicine is manufactured by:

Glaxo Operations UK Ltd., England.

Procured from within the EU and repackaged by:

Doncaster Pharmaceuticals Group Ltd., Kirk Sandall, Doncaster, DN3 1QR.

Product Licence holder:

Doncaster Pharmaceuticals Group Ltd., Kirk Sandall, Doncaster, DN3 1QR.

PL: 04423/0531    POM

Leaflet issue and revision date (Ref): 13.05.16 Zofran® is a registered trademark of Novartis AG.

Other formats:

To listen to or request a copy of this leaflet in Braille, large print or audio please call: 01302 365000. Please be ready to give the following information:

Product name    Reference number

Zofran 8mg Tablets or    04423/0531

Ondansetron 8mg Tablets

Page 2 of 2